Consolidated Statement of Non-Financial Information

The report presents Pharma Mar Group's 2023 non-financial performance across materiality, climate, resource use, employment, supply-chain and ethics topics. It reports submitted science-based climate targets, including a 42% reduction in Scope 1 and 2 emissions by 2030 and a net-zero target for 2050. The report also details 2023 emissions, water consumption and waste management, including 93.3% recovery of non-hazardous waste. Governance disclosures describe Board and committee oversight, an Ethics Channel and anti-corruption controls.